Apolipoprotein A-I binding protein-mediated neuroprotection in glaucomatous neuroinflammation and neurodegeneration  

作　　者：Sinwoo Hwang Seunghwan Choi Soo-Ho Choi Keun-Young Kim Yury I.Miller Won-Kyu Ju 

机构地区：[1]Hamilton Glaucoma Center and Shiley Eye Institute,The Viterbi Family Department of Ophthalmology,University of California San Diego,La Jolla,CA,USA [2]Department of Medicine,University of California San Diego,La Jolla,CA,USA [3]National Center for Microscopy and Imaging Research,Department of Neurosciences,University of California San Diego,La Jolla,CA,USA

出　　处：《Neural Regeneration Research》2025年第5期1414-1415,共2页中国神经再生研究（英文版）

基　　金：supported by the National Institutes of Health grants EY034116 (to WKJ, KYK, and SHC) and AG081037 (to YIM and WKJ)。

摘　　要：Glaucoma is a multifactorial eye disorder that can cause vision loss and irreversible blindness,affecting individ uals aged 40 to 80 yea rs worldwide.Due to the aging population,it is expected that the number of people affected by glaucoma will surpass 111 million by 2040 as the disease becomes more prevalent.Glaucoma primarily contributes to optic nerve axon loss and the progressive degeneration of retinal ganglion cells (RGCs),subsequently leading to vision impairment.

关 键 词：IRREVERSIBLE PASS primarily 

分 类 号：R775[医药卫生—眼科]